As members will know from a communication sent 17 May, the European Parliament (EP) groups, who are giving opinion on the proposal for the FP7 have reached an unofficial agreement on amendments to the Seventh Framework Programme for Research (FP7). EFA are happy that these include the provisions for which we asked for: Translational research in MAJOR diseases, including allergic and respiratory among others; and Clinical research to include allergic and respiratory diseases. The amendments as are due to be voted by the EP next month and we will keep you informed.

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team